世界のナノ抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nano Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5874
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、87ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ナノ抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ）、用途別市場規模（in vitro疾患検出、in vivo非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ナノ抗体の市場動向
・企業の競争状況、市場シェア
・ナノ抗体の種類別市場規模と予測2016-2027（一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ）
・ナノ抗体の用途別市場規模と予測2016-2027（in vitro疾患検出、in vivo非侵襲的診断、腫瘍標的療法、神経系疾患、循環器疾患、感染症、その他）
・ナノ抗体の北米市場規模2016-2027（アメリカ、カナダ）
・ナノ抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ナノ抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ナノ抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・ナノ抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Ablynx、PREGENE、Alphamab、PersonGen）
・結論

Nanoantibodies or “nAb” are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:

Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability

Market Analysis and Insights: Global Nano Antibodies Market
The global Nano Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nano Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nano Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nano Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nano Antibodies market.

Global Nano Antibodies Scope and Market Size
Nano Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nano Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody

Segment by Application
Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ablynx
PREGENE
Alphamab
PersonGen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monovalent Nanobody
1.2.3 Multivalent and multispecific Nanobodies
1.2.4 Fusion Nanobody
1.3 Market by Application
1.3.1 Global Nano Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Disease detection in vitro
1.3.3 Non-invasive diagnosis in vivo
1.3.4 Tumor targeted therapy
1.3.5 Nervous system disease
1.3.6 Circulatory disease
1.3.7 Infectious disease
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nano Antibodies Market Perspective (2016-2027)
2.2 Nano Antibodies Growth Trends by Regions
2.2.1 Nano Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nano Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 Nano Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 Nano Antibodies Industry Dynamic
2.3.1 Nano Antibodies Market Trends
2.3.2 Nano Antibodies Market Drivers
2.3.3 Nano Antibodies Market Challenges
2.3.4 Nano Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nano Antibodies Players by Revenue
3.1.1 Global Top Nano Antibodies Players by Revenue (2016-2021)
3.1.2 Global Nano Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nano Antibodies Revenue
3.4 Global Nano Antibodies Market Concentration Ratio
3.4.1 Global Nano Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano Antibodies Revenue in 2020
3.5 Nano Antibodies Key Players Head office and Area Served
3.6 Key Players Nano Antibodies Product Solution and Service
3.7 Date of Enter into Nano Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nano Antibodies Breakdown Data by Type
4.1 Global Nano Antibodies Historic Market Size by Type (2016-2021)
4.2 Global Nano Antibodies Forecasted Market Size by Type (2022-2027)

5 Nano Antibodies Breakdown Data by Application
5.1 Global Nano Antibodies Historic Market Size by Application (2016-2021)
5.2 Global Nano Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nano Antibodies Market Size (2016-2027)
6.2 North America Nano Antibodies Market Size by Type
6.2.1 North America Nano Antibodies Market Size by Type (2016-2021)
6.2.2 North America Nano Antibodies Market Size by Type (2022-2027)
6.2.3 North America Nano Antibodies Market Size by Type (2016-2027)
6.3 North America Nano Antibodies Market Size by Application
6.3.1 North America Nano Antibodies Market Size by Application (2016-2021)
6.3.2 North America Nano Antibodies Market Size by Application (2022-2027)
6.3.3 North America Nano Antibodies Market Size by Application (2016-2027)
6.4 North America Nano Antibodies Market Size by Country
6.4.1 North America Nano Antibodies Market Size by Country (2016-2021)
6.4.2 North America Nano Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nano Antibodies Market Size (2016-2027)
7.2 Europe Nano Antibodies Market Size by Type
7.2.1 Europe Nano Antibodies Market Size by Type (2016-2021)
7.2.2 Europe Nano Antibodies Market Size by Type (2022-2027)
7.2.3 Europe Nano Antibodies Market Size by Type (2016-2027)
7.3 Europe Nano Antibodies Market Size by Application
7.3.1 Europe Nano Antibodies Market Size by Application (2016-2021)
7.3.2 Europe Nano Antibodies Market Size by Application (2022-2027)
7.3.3 Europe Nano Antibodies Market Size by Application (2016-2027)
7.4 Europe Nano Antibodies Market Size by Country
7.4.1 Europe Nano Antibodies Market Size by Country (2016-2021)
7.4.2 Europe Nano Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nano Antibodies Market Size (2016-2027)
8.2 Asia-Pacific Nano Antibodies Market Size by Type
8.2.1 Asia-Pacific Nano Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nano Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nano Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific Nano Antibodies Market Size by Application
8.3.1 Asia-Pacific Nano Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nano Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nano Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific Nano Antibodies Market Size by Region
8.4.1 Asia-Pacific Nano Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nano Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nano Antibodies Market Size (2016-2027)
9.2 Latin America Nano Antibodies Market Size by Type
9.2.1 Latin America Nano Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America Nano Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America Nano Antibodies Market Size by Type (2016-2027)
9.3 Latin America Nano Antibodies Market Size by Application
9.3.1 Latin America Nano Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America Nano Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America Nano Antibodies Market Size by Application (2016-2027)
9.4 Latin America Nano Antibodies Market Size by Country
9.4.1 Latin America Nano Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America Nano Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nano Antibodies Market Size (2016-2027)
10.2 Middle East & Africa Nano Antibodies Market Size by Type
10.2.1 Middle East & Africa Nano Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nano Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nano Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa Nano Antibodies Market Size by Application
10.3.1 Middle East & Africa Nano Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nano Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nano Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa Nano Antibodies Market Size by Country
10.4.1 Middle East & Africa Nano Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nano Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ablynx
11.1.1 Ablynx Company Details
11.1.2 Ablynx Business Overview
11.1.3 Ablynx Nano Antibodies Introduction
11.1.4 Ablynx Revenue in Nano Antibodies Business (2016-2021)
11.1.5 Ablynx Recent Development
11.2 PREGENE
11.2.1 PREGENE Company Details
11.2.2 PREGENE Business Overview
11.2.3 PREGENE Nano Antibodies Introduction
11.2.4 PREGENE Revenue in Nano Antibodies Business (2016-2021)
11.2.5 PREGENE Recent Development
11.3 Alphamab
11.3.1 Alphamab Company Details
11.3.2 Alphamab Business Overview
11.3.3 Alphamab Nano Antibodies Introduction
11.3.4 Alphamab Revenue in Nano Antibodies Business (2016-2021)
11.3.5 Alphamab Recent Development
11.4 PersonGen
11.4.1 PersonGen Company Details
11.4.2 PersonGen Business Overview
11.4.3 PersonGen Nano Antibodies Introduction
11.4.4 PersonGen Revenue in Nano Antibodies Business (2016-2021)
11.4.5 PersonGen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nano Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monovalent Nanobody
Table 3. Key Players of Multivalent and multispecific Nanobodies
Table 4. Key Players of Fusion Nanobody
Table 5. Global Nano Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nano Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nano Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Nano Antibodies Market Share by Regions (2016-2021)
Table 9. Global Nano Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Nano Antibodies Market Share by Regions (2022-2027)
Table 11. Nano Antibodies Market Trends
Table 12. Nano Antibodies Market Drivers
Table 13. Nano Antibodies Market Challenges
Table 14. Nano Antibodies Market Restraints
Table 15. Global Nano Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Nano Antibodies Market Share by Players (2016-2021)
Table 17. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Antibodies as of 2020)
Table 18. Ranking of Global Top Nano Antibodies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Nano Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nano Antibodies Product Solution and Service
Table 22. Date of Enter into Nano Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Nano Antibodies Revenue Market Share by Type (2016-2021)
Table 26. Global Nano Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Nano Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Nano Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Nano Antibodies Revenue Market Share by Application (2016-2021)
Table 30. Global Nano Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Nano Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Nano Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Nano Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Nano Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Nano Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Nano Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Nano Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Nano Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Nano Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Nano Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Nano Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Nano Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nano Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nano Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nano Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Nano Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Nano Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Nano Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Nano Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Nano Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Nano Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Nano Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Nano Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nano Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nano Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nano Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Nano Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ablynx Company Details
Table 63. Ablynx Business Overview
Table 64. Ablynx Nano Antibodies Product
Table 65. Ablynx Revenue in Nano Antibodies Business (2016-2021) & (US$ Million)
Table 66. Ablynx Recent Development
Table 67. PREGENE Company Details
Table 68. PREGENE Business Overview
Table 69. PREGENE Nano Antibodies Product
Table 70. PREGENE Revenue in Nano Antibodies Business (2016-2021) & (US$ Million)
Table 71. PREGENE Recent Development
Table 72. Alphamab Company Details
Table 73. Alphamab Business Overview
Table 74. Alphamab Nano Antibodies Product
Table 75. Alphamab Revenue in Nano Antibodies Business (2016-2021) & (US$ Million)
Table 76. Alphamab Recent Development
Table 77. PersonGen Company Details
Table 78. PersonGen Business Overview
Table 79. PersonGen Nano Antibodies Product
Table 80. PersonGen Revenue in Nano Antibodies Business (2016-2021) & (US$ Million)
Table 81. PersonGen Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Monovalent Nanobody Features
Figure 3. Multivalent and multispecific Nanobodies Features
Figure 4. Fusion Nanobody Features
Figure 5. Global Nano Antibodies Market Share by Application: 2020 VS 2027
Figure 6. Disease detection in vitro Case Studies
Figure 7. Non-invasive diagnosis in vivo Case Studies
Figure 8. Tumor targeted therapy Case Studies
Figure 9. Nervous system disease Case Studies
Figure 10. Circulatory disease Case Studies
Figure 11. Infectious disease Case Studies
Figure 12. Other Case Studies
Figure 13. Nano Antibodies Report Years Considered
Figure 14. Global Nano Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Nano Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Nano Antibodies Market Share by Regions: 2020 VS 2027
Figure 17. Global Nano Antibodies Market Share by Regions (2022-2027)
Figure 18. Global Nano Antibodies Market Share by Players in 2020
Figure 19. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Antibodies as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Nano Antibodies Revenue in 2020
Figure 21. Global Nano Antibodies Revenue Market Share by Type (2016-2021)
Figure 22. Global Nano Antibodies Revenue Market Share by Type (2022-2027)
Figure 23. North America Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Nano Antibodies Market Share by Type (2016-2027)
Figure 25. North America Nano Antibodies Market Share by Application (2016-2027)
Figure 26. North America Nano Antibodies Market Share by Country (2016-2027)
Figure 27. United States Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Nano Antibodies Market Share by Type (2016-2027)
Figure 31. Europe Nano Antibodies Market Share by Application (2016-2027)
Figure 32. Europe Nano Antibodies Market Share by Country (2016-2027)
Figure 33. Germany Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Nano Antibodies Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Nano Antibodies Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Nano Antibodies Market Share by Region (2016-2027)
Figure 43. China Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Nano Antibodies Market Share by Type (2016-2027)
Figure 51. Latin America Nano Antibodies Market Share by Application (2016-2027)
Figure 52. Latin America Nano Antibodies Market Share by Country (2016-2027)
Figure 53. Mexico Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Nano Antibodies Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Nano Antibodies Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Nano Antibodies Market Share by Country (2016-2027)
Figure 59. Turkey Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Nano Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Ablynx Revenue Growth Rate in Nano Antibodies Business (2016-2021)
Figure 63. PREGENE Revenue Growth Rate in Nano Antibodies Business (2016-2021)
Figure 64. Alphamab Revenue Growth Rate in Nano Antibodies Business (2016-2021)
Figure 65. PersonGen Revenue Growth Rate in Nano Antibodies Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の二重特異性抗体市場規模・現状・予測（2021年-2027年）

Global Bi-Specific Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5623 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、二重特異性抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Bispecific Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5624 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、二重特異性モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、ア...

世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-3853 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、関節炎モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レミケード、ヒュミラ、エンブレル、リツキサン、オレンシア、アクテムラ、シンポニ、シムジア）、用途別市場規模（関節リウマチ、変形性...

世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年）

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2021-2027
QFJ1-4941 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、タンパク質＆抗体＆核酸デリバリー技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、...

世界のナノ歯科市場規模・現状・予測（2021年-2027年）

Global Nano-Dentistry Market Size, Status and Forecast 2021-2027
QFJ1-5261 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、ナノ歯科の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ナノセラミック、ナノフィラー、ナノロボット、その他）、用途別市場規模（病院、歯科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のナノ化学療法市場規模・現状・予測（2021年-2027年）

Global Nano ChemOthersapy Market Size, Status and Forecast 2021-2027
QFJ1-4547 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、ナノ化学療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療療法、理学療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の研究用抗体＆試薬市場規模・現状・予測（2021年-2027年）

Global Research Antibodies & Reagents Market Size, Status and Forecast 2021-2027
QFJ1-4813 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、研究用抗体＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ウエスタンブロッティング、蛍光抗体法、免疫吸着測定法、フローサイトメトリー、免疫組織化学、免疫沈降）、用途別市場規模（プロテオミクス、創...

世界の食品＆飲料ナノ技術包装市場規模・現状・予測（2021年-2027年）

Global Food And Beverage Nano-Enabled Packaging Market Size, Status and Forecast 2021-2027
QFJ1-2352 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、食品＆飲料ナノ技術包装の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アクティブパッケージング、インテリジェントパッケージング、制御パッケージング）、用途別市場規模（果物＆野菜、飲料、惣菜、肉製品、ベ...

世界のナノメカニカルテスト市場規模・現状・予測（2021年-2027年）

Global Nano-Mechanical Testing Market Size, Status and Forecast 2021-2027
QFJ1-3562 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ナノメカニカルテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ナノインデント、ナノスクラッチ、ナノインパクト、ナノトライボロジー、その他）、用途別市場規模（先端材料開発、工業製造、計測学、コーテ...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界の植物病理＆病害診断市場規模・現状・予測（2021年-2027年） Plant disease diagnostic networks have developed worldwide to address the problems of efficient and effective disease diagnosis and pathogen detection, engendering cooperation of institutions and experts within countries and across national borders. Market Analysis and Insights: Global Phytopatholog…
世界の鎌状赤血球症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sickle Cell Disease Diagnosis Market The global Sickle Cell Disease Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界のウイルス性疾患診断市場規模・現状・予測（2021年-2027年） Viral Disease Diagnosis is based on clinical features and pathological data to determine the possible infection of viruses. Then according to the biological characteristics of suspicious viruses, immune response and clinical process, combined with the patient's current time. Market Analysis and Insi…
世界の炎症性腸疾患体外診断市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indicatio…
世界の手足口病分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing Hand, Foot and Mouth Disease Market Analysis and Insights: Global Molecular Diagnosis of Hand, Foot and Mouth Disease Market The global Molecular Diagnosis of Hand, Foot and Mouth Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…